USPTO Art Unit 1683 Prosecution Statistics

Art Unit Information

Art Unit: 1683
Group: 1680
Tech Center: 1600
Total Cases: 1,053
Last Active: March 2025

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19073932SPATIALLY ENCODED BIOLOGICAL ASSAYSMarch 2025June 2025Allow400YesNo
19074001SPATIALLY ENCODED BIOLOGICAL ASSAYSMarch 2025July 2025Allow400NoNo
19053925IN SITU COMBINATORIAL LABELING OF CELLULAR MOLECULESFebruary 2025June 2025Allow410NoNo
19048060MULTIOMIC ANALYSIS DEVICE AND METHODS OF USE THEREOFFebruary 2025May 2025Allow400NoNo
18988119METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLEDecember 2024April 2025Allow400YesNo
18987997METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLEDecember 2024April 2025Allow400YesNo
18972052SPATIALLY ENCODED BIOLOGICAL ASSAYSDecember 2024March 2025Allow300YesNo
18972148SPATIALLY ENCODED BIOLOGICAL ASSAYSDecember 2024April 2025Allow400NoNo
18940111MICROFLUIDIC DEVICE AND METHOD OF MANUFACTURING THE SAMENovember 2024February 2025Allow300NoNo
18926208COMPOSITIONS AND METHODS FOR GENE EXPRESSION LIBRARY ANALYSISOctober 2024January 2025Allow300YesNo
18793359SPATIALLY ENCODED BIOLOGICAL ASSAYSAugust 2024December 2024Allow500YesNo
18789541METHODS AND SYSTEMS FOR TARGETED RNA CLEAVAGE AND TARGET RNA-PRIMED ROLLING CIRCLE AMPLIFICATIONJuly 2024February 2025Allow610YesNo
18759368DETECTION AND DIGITAL QUANTITATION OF MULTIPLE TARGETSJune 2024November 2024Allow510YesNo
18745574DETECTION AND DIGITAL QUANTITATION OF MULTIPLE TARGETSJune 2024February 2025Allow810NoNo
18663425APPARATUS AND METHODS FOR IDENTIFICATION OF MICROBIAL PRESENCEMay 2024November 2024Allow600YesNo
18649255METHODS, COMPOSITIONS, AND KITS FOR DETERMINING THE LOCATION OF AN ANALYTE IN A BIOLOGICAL SAMPLEApril 2024February 2025Allow910NoNo
18602633MOLECULAR WIRES FOR DETECTING A BIOLOGICAL OR CHEMICAL ENTITY OR EVENTMarch 2024August 2024Allow510NoNo
18589354COMPOSITIONS AND METHODS FOR GENE EXPRESSION LIBRARY ANALYSISFebruary 2024August 2024Allow610YesNo
18443079METHODS FOR IN SITU TRANSCRIPTOMICS AND PROTEOMICSFebruary 2024February 2025Allow1220NoNo
18441187METHODS FOR EARLY DETECTION OF CANCERFebruary 2024June 2024Allow410NoNo
18431748MULTIVALENT BINDING COMPOSITION FOR NUCLEIC ACID ANALYSISFebruary 2024January 2025Allow1111YesNo
18417995OPTICAL SYSTEMS FOR NUCLEIC ACID SEQUENCING AND METHODS THEREOFJanuary 2024July 2024Allow610NoNo
18405371LUNG CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODJanuary 2024April 2025Allow1600NoNo
18389901IN SITU COMBINATORIAL LABELING OF CELLULAR MOLECULESDecember 2023October 2024Allow1010NoNo
18539226MICROFLUIDIC DEVICE AND METHOD OF MANUFACTURING THE SAMEDecember 2023August 2024Allow801NoNo
18538488NON-INVASIVE DETECTION OF FETAL GENETIC TRAITSDecember 2023April 2025Abandon1620NoNo
18514603BREAST CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODNovember 2023April 2025Allow1700NoNo
18509767STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODNovember 2023March 2025Allow1600NoNo
18502378BIOMARKER FOR PREDICTING AGE IN DAYS OF PIGS, AND PREDICTION METHODNovember 2023April 2025Abandon1821NoNo
18491272LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODOctober 2023August 2024Allow1000YesNo
18479622MULTIPLEXED PROFILING OF RNA AND DNA MODIFICATIONSOctober 2023February 2025Allow1711YesNo
18473061DNA Damage Repair Inhibitors for Treatment of CancerSeptember 2023March 2025Abandon1801NoNo
18469871IN SITU DETECTION OF NUCLEIC ACID MOLECULESSeptember 2023February 2025Allow1720NoNo
18243582METHODS FOR IMPROVED IN SITU DETECTION OF NUCLEIC ACIDS AND SPATIAL ANALYSISSeptember 2023August 2024Allow1221YesNo
18455527METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTAugust 2023June 2025Abandon2231NoNo
18455456METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTAugust 2023June 2025Abandon2231NoNo
18455488METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENTAugust 2023May 2025Abandon2021NoNo
18361440BILIARY TRACT CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODJuly 2023July 2024Allow1200NoNo
18355291RNA TEMPLATED LIGATIONJuly 2023September 2024Allow1410YesNo
18352957MULTIOMIC ANALYSIS DEVICE AND METHODS OF USE THEREOFJuly 2023January 2025Allow1831NoNo
18348072METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLEJuly 2023November 2024Allow1630YesNo
18345629METHODS AND SYSTEMS FOR SPATIAL MAPPING OF GENETIC VARIANTSJune 2023September 2024Allow1410YesNo
18215608SMALL RNA PREDICTORS FOR HUNTINGTON'S DISEASEJune 2023February 2025Abandon2001NoNo
18343028RNA AND DNA ANALYSIS USING ENGINEERED SURFACESJune 2023November 2024Allow1711YesNo
18210970IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5 PRIME ENDSJune 2023August 2024Allow1421YesNo
18335936MULTIPLEXED TARGETED AMPLIFICATION OF POLYNUCLEOTIDESJune 2023September 2024Allow1521YesNo
18324890HIGH THROUGHPUT MULTIOMICS SAMPLE ANALYSISMay 2023May 2025Allow2420NoNo
18324880HIGH THROUGHPUT MULTIOMICS SAMPLE ANALYSISMay 2023May 2025Allow2420NoNo
18323922CANCER TREATMENTS AND METHODS OF SELECTING SAMEMay 2023April 2025Abandon2301NoNo
18304670IN SITU COMBINATORIAL LABELING OF CELLULAR MOLECULESApril 2023August 2024Allow1610YesNo
18304695IN SITU COMBINATORIAL LABELING OF CELLULAR MOLECULESApril 2023August 2024Allow1610NoNo
18185154METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERSMarch 2023January 2025Abandon2211NoNo
18177238MULTIOMIC ANALYSIS DEVICE AND METHODS OF USE THEREOFMarch 2023January 2025Allow2240NoNo
18170241ASSOCIATION OF GENETIC VARIATIONS TO DIAGNOSE AND TREAT ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)February 2023July 2024Allow1711YesNo
18160918SYSTEMS AND METHODS FOR DETECTING MULTI-MOLECULE BIOMARKERSJanuary 2023September 2024Allow1921YesNo
18096975METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERSJanuary 2023February 2025Abandon2501NoNo
18091186CIRCULATING RNA SIGNATURES SPECIFIC TO PREECLAMPSIADecember 2022August 2024Allow2021YesNo
18068739MUTANT REVERSE TRANSCRIPTASE WITH INCREASED THERMAL STABILITY AS WELL AS PRODUCTS, METHODS AND USES INVOLVING THE SAMEDecember 2022October 2024Allow2200YesNo
18061273CANCER DETECTION AND CLASSIFICATION USING METHYLOME ANALYSISDecember 2022August 2024Allow2120YesNo
17994541METHODS FOR SEQUENCING A POLYNUCLEOTIDE TEMPLATENovember 2022April 2025Abandon2901NoNo
18047198QUANTITATIVE PCR-BASED ENVIRONMENTAL DNA ASSAYSOctober 2022June 2025Abandon3211NoNo
17934540SCALABLE BACK-GATED FUNCTIONALIZED GRAPHENE FIELD EFFECT TRANSISTORS FOR DETECTION OF DNA AND OTHER TARGET MOLECULESSeptember 2022March 2025Allow3001NoNo
17946948APPARATUS FOR EFFICIENT GENETIC MODIFICATION OF CELLSSeptember 2022July 2024Allow2200YesNo
17945243COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODSeptember 2022October 2024Abandon2520NoNo
17822793Methods for Nucleic Acid Sequence DetectionAugust 2022April 2025Allow3120YesNo
17821950ADAPTORS FOR NUCLEIC ACID CONSTRUCTS IN TRANSMEMBRANE SEQUENCINGAugust 2022May 2025Abandon3311NoNo
17800334CALIBRATION SET INCLUDING NANOPARTICLES OF NYLON-6 AND DYESAugust 2022June 2025Allow3400NoNo
17816985COMPOSITIONS AND METHODS FOR ROLLING CIRCLE AMPLIFICATIONAugust 2022April 2025Allow3231YesNo
17816988STABILIZATION AND/OR COMPACTION OF NUCLEIC ACID MOLECULESAugust 2022July 2025Allow3521YesNo
17816841IN SITU MONITORING OF TRANSCRIPT AND PROTEIN TARGETSAugust 2022March 2024Allow2030YesNo
17816210METHODS AND KITS COMPRISING GENE SIGNATURES FOR STRATIFYING BREAST CANCER PATIENTSJuly 2022July 2024Allow2311YesNo
17876871AN ACTIVE-ELECTRODE INTEGRATED BIOSENSOR ARRAY AND METHODS FOR USE THEREOFJuly 2022April 2025Abandon3210NoNo
17877695CIRCULARIZABLE PROBES FOR IN SITU ANALYSISJuly 2022July 2024Allow2311YesNo
17815815METHOD OF IMPROVED SEQUENCING BY STRAND IDENTIFICATIONJuly 2022November 2024Allow2710NoNo
17870886HERITABLE EPIGENETIC MODIFICATIONS AS MARKERS OF CHEMOTHERAPY EXPOSUREJuly 2022June 2025Abandon3521NoNo
17741708CHARACTERIZATION OF MOLECULES IN NANOFLUIDICSMay 2022December 2024Allow3110YesNo
17662841BARCODE-FREE SINGLE VESICLE MULTIPLEXED PROTEIN AND RNA ANALYSISMay 2022December 2024Abandon3110NoNo
17736684Methods for Fluorescence Imaging Microscopy and Nano-FishMay 2022November 2024Allow3010NoNo
17661578THERMAL SENSOR ARRAY FOR MOLECULE DETECTION AND RELATED DETECTION SCHEMESMay 2022April 2025Allow3500NoNo
17726809Processes and Compositions for Methylation-Based Enrichment of Fetal Nucleic Acid From a Maternal Sample Useful for Non-Invasive Prenatal DiagnosesApril 2022February 2025Abandon3421NoNo
17724335CHARACTERISTIC ANALYSIS METHOD AND CLASSIFICATION OF PHARMACEUTICAL COMPONENTS BY USING TRANSCRIPTOMESApril 2022October 2024Abandon3001NoNo
17720210METHODS FOR SEAMLESS NUCLEIC ACID ASSEMBLYApril 2022October 2024Allow3010NoNo
17716606FIXATIVES AND METHODS OF USEApril 2022December 2024Allow3210NoNo
17713934SEQUENCING USING NON-NATURAL NUCLEOTIDESApril 2022November 2024Allow3111YesNo
17704691OPTICAL SYSTEM AND ASSAY CHIP FOR PROBING, DETECTING AND ANALYZING MOLECULESMarch 2022April 2025Abandon3711NoNo
17699849CHEMICAL COMPOSITIONS AND METHODS OF USING SAMEMarch 2022December 2024Allow3210NoNo
17654938CAPTURING SPECIFIC NUCLEIC ACID MATERIALS FROM INDIVIDUAL BIOLOGICAL CELLS IN A MICRO-FLUIDIC DEVICEMarch 2022November 2024Abandon3210NoNo
17689237METHODS FOR SEQUENCING POLYNUCLEOTIDESMarch 2022January 2025Allow3511YesNo
17687473THERMOSTABLE POLYMERASE INHIBITOR COMPOSITIONS AND METHODSMarch 2022April 2025Allow3721YesNo
17683856SEQUENTIAL HYBRIDIZATION AND QUENCHINGMarch 2022December 2024Allow3300YesNo
17676070OPTICAL SYSTEM AND ASSAY CHIP FOR PROBING, DETECTING AND ANALYZING MOLECULESFebruary 2022July 2024Allow2910NoNo
17636842METHOD AND SYSTEM FOR MEASURING ANALYTE CONCENTRATION IN A SAMPLEFebruary 2022July 2025Allow4001NoNo
17636403OPTIMIZED NUCLEIC ACID PROBES FOR ANALYTE DETECTIONFebruary 2022June 2025Abandon3901NoNo
17634787SORTING A DROPLET INCLUDING A BIOLOGIC SAMPLEFebruary 2022May 2025Allow3911NoNo
17669081METHODS FOR PROFILING AND QUANTITATING CELL-FREE RNAFebruary 2022March 2025Allow3731YesYes
17634223METHOD FOR DETERMINING IF A TUMOR HAS A MUTATION IN A MICROSATELLITEFebruary 2022April 2025Allow3810NoNo
17576188Methods, Compositions, and Systems for Detecting Silent Carriers of Spinal Muscular AtrophyJanuary 2022June 2025Abandon4111NoNo
17575928METHODS AND MATERIALS FOR ASSESSING RNA EXPRESSIONJanuary 2022December 2024Abandon3501NoNo
17566669Serum miRNA Markers for Diagnosing Liver Cancer and Predicting Liver Cancer Metastasis and Detection Kit ThereofDecember 2021March 2025Allow3910NoNo
17621989METHODS AND DEVICES FOR IDENTIFYING PATHOGENS AND ANTIBODIES AND TREATMENT DEVICE THEREFOREDecember 2021May 2025Abandon4101NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 1683.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
9
Examiner Affirmed
5
(55.6%)
Examiner Reversed
4
(44.4%)
Reversal Percentile
89.3%
Higher than average

What This Means

With a 44.4% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
90
Allowed After Appeal Filing
35
(38.9%)
Not Allowed After Appeal Filing
55
(61.1%)
Filing Benefit Percentile
80.8%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 38.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Art Unit 1683 - Prosecution Statistics Summary

Executive Summary

Art Unit 1683 is part of Group 1680 in Technology Center 1600. This art unit has examined 1,053 patent applications in our dataset, with an overall allowance rate of 91.4%. Applications typically reach final disposition in approximately 36 months.

Comparative Analysis

Art Unit 1683's allowance rate of 91.4% places it in the 93% percentile among all USPTO art units. This art unit has a significantly higher allowance rate than most art units at the USPTO.

Prosecution Patterns

Applications in Art Unit 1683 receive an average of 2.30 office actions before reaching final disposition (in the 84% percentile). The median prosecution time is 36 months (in the 16% percentile).

Strategic Considerations

When prosecuting applications in this art unit, consider the following:

  • The art unit's allowance rate suggests a more favorable examination environment compared to the USPTO average.
  • With more office actions than average, plan for multiple rounds of prosecution.
  • The median prosecution time is longer than average and should be factored into your continuation and client communication strategies.
  • Review individual examiner statistics within this art unit to identify examiners with particularly favorable or challenging prosecution patterns.

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.